Pulmonary Rehabilitation Before Lung Cancer Resection

NCT02887521 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2025-02-03

Study results available
· View outcomes & findings →

Summary

This is a study funded by the National Institute of Health. The rationale for the need of this research is the lack of any well proven risk-reducing intervention that may decrease the morbidity of lung cancer resection in patients with COPD or that may improve their quality of life trajectory, a meaningful outcome in the overall disease progression. The proposed intervention is unique as it combines exercise and behavioral interventions that were pilot tested in a randomized single-blinded controlled design in the proposed population and proved feasible and potentially effective. The aim is to test the effect of the proposed rehabilitation on length of stay, pulmonary complications and quality of life trajectory.

Conditions

  • Non-small Cell Lung Cancer (NSCLC)
  • Chronic Obstructive Pulmonary Disease (COPD)

Interventions

OTHER

education

pulmonary rehabilitation participant manual

PROCEDURE

rehabilitation

pulmonary rehabilitation

DEVICE

pedometer

receive a pedometer

OTHER

education

receive a pamphlet with exercises plus the standard course of care

PROCEDURE

surgery

patients undergo surgery

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Alliance for Clinical Trials in Oncology

    lead OTHER

Principal Investigators

  • Robert Benzo, MD, MSc · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-28
Primary Completion
2019-04-22
Completion
2019-09-25

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02887521 on ClinicalTrials.gov